Cargando…
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
Deregulation of noncoding RNAs, including microRNAs (miRs), is implicated in the pathogenesis of many human cancers, including breast cancer. Through extensive analysis of The Cancer Genome Atlas, we found that expression of miR-22-3p is markedly lower in triple-negative breast cancer (TNBC) than in...
Autores principales: | Gorur, Aysegul, Bayraktar, Recep, Ivan, Cristina, Mokhlis, Hamada Ahmed, Bayraktar, Emine, Kahraman, Nermin, Karakas, Didem, Karamil, Selda, Kabil, Nashwa N., Kanlikilicer, Pinar, Aslan, Burcu, Tamer, Lulufer, Wang, Zhihui, Cristini, Vittorio, Lopez-Berestein, Gabriel, Calin, George, Ozpolat, Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868999/ https://www.ncbi.nlm.nih.gov/pubmed/33614241 http://dx.doi.org/10.1016/j.omtn.2021.01.016 |
Ejemplares similares
-
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016) -
Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023) -
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
por: Mokhlis, Hamada A., et al.
Publicado: (2018) -
Adjacent Nucleotide Dependence in ncRNA and Order-1 SCFG for ncRNA Identification
por: Wong, Thomas K. F., et al.
Publicado: (2010) -
A Keystone for ncRNA
por: Hacisuleyman, Ezgi, et al.
Publicado: (2012)